Articles
29.05.2019
What are precision medicines

What is the future of precision medicine in the EU? The field of precision medicine is a complex are...

Read more
Articles
28.05.2019
NICE scientific advice re Brexit

NICE will continue to offer joint advice with the Medicines and Healthcare products Regulatory Agenc...

Read more
Articles
07.03.2019
NICE evidence request for Blincyto

Conclusion: Blincyto has significant clinical benefits, but that further evidence on cost-effective...

Read more
Articles
06.03.2019
NHS England medicines chief faster market access

NHS England continues to develop its pricing and reimbursement expertise by appointing Blake Dark, a...

Read more
Articles
01.03.2019
NICE recommends treatment for early breast cancer

NICE's final appraisal indicates that Roche has offered the NHS a discount on the drug, which carrie...

Read more
Articles
27.02.2019
Faster patient access in France

If the French government is able to deliver, pharmaceutical companies can look forward to potentiall...

Read more
Articles
22.02.2019
High Pharma Margins

Cancer drug prices are rising rapidly, and profit margins for pharmaceutical companies reach upwards...

Read more
Articles
14.02.2019
Official META Tool facilitators

As facilitators we can help companies understand what payer evidence is required to demonstrate the ...

Read more
Articles
11.02.2019
NICE Scientific Advice

The collaboration with the Ethical Medicines Industry Group (EMIG) will help bring greater understan...

Read more
Articles
29.01.2019
Voluntary scheme for branded medicines pricing

Overall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.